Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)
China
· Delayed Price · Currency is CNY 20.30
+0.40 (2.01%)
Mar 10, 2026, 3:00 PM CST
Shanghai ZJ Bio-Tech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -127.46 | -136.86 | 760.27 | 758.52 | Upgrade
|
| Depreciation & Amortization | - | 67.71 | 66.69 | 60.24 | 24.84 | Upgrade
|
| Other Amortization | - | 1.42 | 0.59 | 0.08 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.04 | - | -0.03 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 22.53 | 1.15 | 0.59 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.06 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | 8.41 | 1.36 | 6.35 | 5.38 | Upgrade
|
| Other Operating Activities | - | 134.73 | 169.99 | -62.76 | 28.33 | Upgrade
|
| Change in Accounts Receivable | - | 37.31 | 114.77 | 12.17 | -25.19 | Upgrade
|
| Change in Inventory | - | 36.37 | 31.72 | -297.19 | -172.51 | Upgrade
|
| Change in Accounts Payable | - | -81.05 | -304.21 | 104.49 | 16.72 | Upgrade
|
| Change in Other Net Operating Assets | - | 0.98 | 0.61 | 1.18 | 5.86 | Upgrade
|
| Operating Cash Flow | - | 77.59 | -81.88 | 584.97 | 641.94 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -8.87% | -43.78% | Upgrade
|
| Capital Expenditures | - | -19.49 | -81.15 | -74.56 | -498.06 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.01 | 1.14 | 0.06 | - | Upgrade
|
| Investment in Securities | - | 0.06 | 2.32 | -1.53 | -21 | Upgrade
|
| Investing Cash Flow | - | -19.42 | -77.69 | -76.02 | -519.06 | Upgrade
|
| Long-Term Debt Repaid | - | -2.51 | -3.65 | -3.75 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -2.51 | -3.65 | -3.75 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,959 | Upgrade
|
| Repurchase of Common Stock | - | -35.33 | - | -102.03 | - | Upgrade
|
| Common Dividends Paid | - | -20.88 | -230.74 | -265.62 | -311.53 | Upgrade
|
| Other Financing Activities | - | - | - | - | -19.3 | Upgrade
|
| Financing Cash Flow | - | -58.72 | -234.39 | -371.4 | 1,628 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 14.44 | 15.77 | 74.35 | -19.82 | Upgrade
|
| Net Cash Flow | - | 13.89 | -378.19 | 211.9 | 1,731 | Upgrade
|
| Free Cash Flow | - | 58.1 | -163.03 | 510.41 | 143.88 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 254.76% | -86.52% | Upgrade
|
| Free Cash Flow Margin | - | 32.52% | -59.43% | 21.94% | 7.13% | Upgrade
|
| Free Cash Flow Per Share | - | 0.30 | -0.85 | 2.64 | 0.76 | Upgrade
|
| Cash Income Tax Paid | - | 17.21 | 52.97 | 188.93 | 261.3 | Upgrade
|
| Levered Free Cash Flow | - | 42.13 | -98.85 | 410.82 | -144.71 | Upgrade
|
| Unlevered Free Cash Flow | - | 42.35 | -98.63 | 411.11 | -144.71 | Upgrade
|
| Change in Working Capital | - | -29.64 | -184.81 | -179.76 | -175.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.